Avastin as Good as Lucentis for AMD (CME/CE)

(MedPage Today) -- Bevacizumab (Avastin) appears to have efficacy similar to that of ranibizumab (Lucentis) for the treatment of neovascular age-related macular degeneration, and monthly administration may offer some advantages over as-needed treatment, randomized trial results showed.

Full Story →